Related Experiment Video
Updated: May 17, 2026

12:18
In Vivo Methods to Assess Retinal Ganglion Cell and Optic Nerve Function and Structure in Large Animals
Published on: February 26, 2022
Copper toxicosis in a Boer goat
Laura C Cregar1, Charles E Wiedmeyer, Davin R Ringen
1Veterinary Medical Diagnostic Laboratory, University of Missouri, Columbia, MO, USA. laura.cregar@mpiresearch.com
Veterinary Clinical Pathology
|November 6, 2012
Summary
Boer goats may be susceptible to copper toxicosis, leading to hemolytic anemia and organ damage. This case highlights the potential for severe health crises in this breed due to copper accumulation.
Area of Science:
- Veterinary Medicine
- Toxicology
- Animal Science
Background:
- Copper toxicosis is a significant concern in livestock, potentially leading to hemolytic crises.
- Boer goats are increasingly recognized as a breed susceptible to copper accumulation and toxicity.
Observation:
- A 1-year-old Boer goat presented with pigmenturia, anorexia, shivering, and progressive hemolytic anemia.
- Clinical signs included Heinz bodies, atypical red blood cells, elevated liver enzymes, hyperbilirubinemia, and azotemia.
Findings:
- Histopathology and ante-mortem hepatic tissue analysis confirmed copper accumulation and hepatocellular necrosis.
- Post-mortem examination revealed hepatic necrosis and hemoglobinuric nephrosis, with markedly increased copper concentrations in liver and kidney.
- No external toxins or mineral imbalances were identified in the water, hay, or goat chow.
Implications:
- This case underscores the predisposition of Boer goats to copper toxicosis, similar to sheep.
- The underlying mechanisms of hepatic copper accumulation and release in Boer goats require further investigation.
- Early recognition and understanding of copper toxicosis are crucial for managing hemolytic crises in susceptible goat breeds.
More Related Videos
Related Concept Videos
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

